Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats.

Indian journal of pharmacology

Kulkarni KS, Kasture SB, Mengi SA.
PMID: 20871769
Indian J Pharmacol. 2010 Jun;42(3):168-73. doi: 10.4103/0253-7613.66841.

OBJECTIVE: Cognitive disorders such as amnesia, attention deficit and Alzheimer's disease are emerging nightmares in the field of medicine because no exact cure exists for them, as existing nootropic agents (piractam, tacrine, metrifonate) have several limitations. The present study...

Cite
Kulkarni KS, Kasture SB, Mengi SA. Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol. 2010;42(3):168-73doi: 10.4103/0253-7613.66841.
Kulkarni, K. S., Kasture, S. B., & Mengi, S. A. (2010). Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian journal of pharmacology, 42(3), 168-73. https://doi.org/10.4103/0253-7613.66841
Kulkarni, Kirti S, et al. "Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats." Indian journal of pharmacology vol. 42,3 (2010): 168-73. doi: https://doi.org/10.4103/0253-7613.66841
Kulkarni KS, Kasture SB, Mengi SA. Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol. 2010 Jun;42(3):168-73. doi: 10.4103/0253-7613.66841. PMID: 20871769; PMCID: PMC2937319.
Copy Download .nbib Format: NLM
Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.

Drugs in context

Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY.
PMID: 24432046
Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13.

OBJECTIVE: Functional outcomes were measured over a 12-month period in children and adolescents with attention deficit hyperactivity disorder (ADHD) after they received monotherapy.DESIGN: Prospective, observational, noninterventional study.SETTING: Conducted in six non-Western countries.PARTICIPANTS: Outpatients 6 to 17 years of age...

Cite
Altin M, El-Shafei AA, Yu M, et al. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs Context. 2013;2013:212260doi: 10.7573/dic.212260.
Altin, M., El-Shafei, A. A., Yu, M., Desaiah, D., Treuer, T., Zavadenko, N., & Gao, H. Y. (2013). Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs in context, 2013212260. https://doi.org/10.7573/dic.212260
Altin, Murat, et al. "Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries." Drugs in context vol. 2013 (2013): 212260. doi: https://doi.org/10.7573/dic.212260
Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13. PMID: 24432046; PMCID: PMC3884848.
Copy Download .nbib Format: NLM
Non-medical use of methylphenidate: a review.

Trends in psychiatry and psychotherapy

Freese L, Signor L, Machado C, Ferigolo M, Barros HM.
PMID: 25922930
Trends Psychiatry Psychother. 2012;34(2):110-5. doi: 10.1590/s2237-60892012000200010.

INTRODUCTION: Methylphenidate is a psychostimulant medication used for the treatment of attention deficit hyperactivity disorder and narcolepsy. However, it has also been used for non-medical purposes, e.g. to produce euphoria, to increase self-esteem, and to achieve the so-called neurocognitive...

Cite
Freese L, Signor L, Machado C, et al. Non-medical use of methylphenidate: a review. Trends Psychiatry Psychother. 2012;34(2):110-5doi: 10.1590/s2237-60892012000200010.
Freese, L., Signor, L., Machado, C., Ferigolo, M., & Barros, H. M. (2012). Non-medical use of methylphenidate: a review. Trends in psychiatry and psychotherapy, 34(2), 110-5. https://doi.org/10.1590/s2237-60892012000200010
Freese, Luana, et al. "Non-medical use of methylphenidate: a review." Trends in psychiatry and psychotherapy vol. 34,2 (2012): 110-5. doi: https://doi.org/10.1590/s2237-60892012000200010
Freese L, Signor L, Machado C, Ferigolo M, Barros HM. Non-medical use of methylphenidate: a review. Trends Psychiatry Psychother. 2012;34(2):110-5. doi: 10.1590/s2237-60892012000200010. PMID: 25922930.
Copy Download .nbib Format: NLM
Acute Psychosis Associated with Phenibut Ingestion.

Kansas journal of medicine

Acosta E, Munguti C.
PMID: 34888004
Kans J Med. 2021 Dec 02;14:308-309. doi: 10.17161/kjm.vol14.15550. eCollection 2021.

No abstract available.

Cite
Acosta E, Munguti C. Acute Psychosis Associated with Phenibut Ingestion. Kans J Med. 2021;14:308-309doi: 10.17161/kjm.vol14.15550.
Acosta, E., & Munguti, C. (2021). Acute Psychosis Associated with Phenibut Ingestion. Kansas journal of medicine, 14308-309. https://doi.org/10.17161/kjm.vol14.15550
Acosta, Eric, and Munguti, Cyrus. "Acute Psychosis Associated with Phenibut Ingestion." Kansas journal of medicine vol. 14 (2021): 308-309. doi: https://doi.org/10.17161/kjm.vol14.15550
Acosta E, Munguti C. Acute Psychosis Associated with Phenibut Ingestion. Kans J Med. 2021 Dec 02;14:308-309. doi: 10.17161/kjm.vol14.15550. eCollection 2021. PMID: 34888004; PMCID: PMC8647977.
Copy Download .nbib Format: NLM
The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model.

Annals of rehabilitation medicine

Song MK, Seon HJ, Kim IG, Han JY, Choi IS, Lee SG.
PMID: 22837964
Ann Rehabil Med. 2012 Jun;36(3):303-10. doi: 10.5535/arm.2012.36.3.303. Epub 2012 Jun 30.

OBJECTIVE: To investigate the effect of combined therapy of exercise and nootropic agent on cognitive function in a focal cerebral infarction rat model.METHOD: Forty 10-week old male Sprague-Dawley rats were subjected to photothrombotic cerebral infarction of the left parietal...

Cite
Song MK, Seon HJ, Kim IG, et al. The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model. Ann Rehabil Med. 2012;36(3):303-10doi: 10.5535/arm.2012.36.3.303.
Song, M. K., Seon, H. J., Kim, I. G., Han, J. Y., Choi, I. S., & Lee, S. G. (2012). The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model. Annals of rehabilitation medicine, 36(3), 303-10. https://doi.org/10.5535/arm.2012.36.3.303
Song, Min-Keun, et al. "The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model." Annals of rehabilitation medicine vol. 36,3 (2012): 303-10. doi: https://doi.org/10.5535/arm.2012.36.3.303
Song MK, Seon HJ, Kim IG, Han JY, Choi IS, Lee SG. The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model. Ann Rehabil Med. 2012 Jun;36(3):303-10. doi: 10.5535/arm.2012.36.3.303. Epub 2012 Jun 30. PMID: 22837964; PMCID: PMC3400868.
Copy Download .nbib Format: NLM
Brahmi rasayana improves learning and memory in mice.

Evidence-based complementary and alternative medicine : eCAM

Joshi H, Parle M.
PMID: 16550227
Evid Based Complement Alternat Med. 2006 Mar;3(1):79-85. doi: 10.1093/ecam/nek014. Epub 2006 Jan 16.

Cure of cognitive disorders such as amnesia, attention deficit and Alzheimer's disease is still a nightmare in the field of medicine. Nootropic agents such as piracetam, aniracetam and choline esterase inhibitors like Donepezil are being used to improve memory,...

Cite
Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. Evid Based Complement Alternat Med. 2006;3(1):79-85doi: 10.1093/ecam/nek014.
Joshi, H., & Parle, M. (2006). Brahmi rasayana improves learning and memory in mice. Evidence-based complementary and alternative medicine : eCAM, 3(1), 79-85. https://doi.org/10.1093/ecam/nek014
Joshi, Hanumanthachar, and Parle, Milind. "Brahmi rasayana improves learning and memory in mice." Evidence-based complementary and alternative medicine : eCAM vol. 3,1 (2006): 79-85. doi: https://doi.org/10.1093/ecam/nek014
Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. Evid Based Complement Alternat Med. 2006 Mar;3(1):79-85. doi: 10.1093/ecam/nek014. Epub 2006 Jan 16. PMID: 16550227; PMCID: PMC1375237.
Copy Download .nbib Format: NLM
Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation.

Journal of clinical medicine

Cichon N, Wlodarczyk L, Saluk-Bijak J, Bijak M, Redlicka J, Gorniak L, Miller E.
PMID: 34501229
J Clin Med. 2021 Aug 24;10(17). doi: 10.3390/jcm10173778.

Aphasia is one of the most common clinical features of functional impairment after a stroke. Approximately 21-40% of stroke patients sustain permanent aphasia, which progressively worsens one's quality of life and rehabilitation outcomes. Post-stroke aphasia treatment strategies include speech...

Cite
Cichon N, Wlodarczyk L, Saluk-Bijak J, et al. Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173778.
Cichon, N., Wlodarczyk, L., Saluk-Bijak, J., Bijak, M., Redlicka, J., Gorniak, L., & Miller, E. (2021). Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173778
Cichon, Natalia, et al. "Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173778
Cichon N, Wlodarczyk L, Saluk-Bijak J, Bijak M, Redlicka J, Gorniak L, Miller E. Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation. J Clin Med. 2021 Aug 24;10(17). doi: 10.3390/jcm10173778. PMID: 34501229; PMCID: PMC8432240.
Copy Download .nbib Format: NLM
Perspectives in the treatment of vascular dementia.

Drugs of today (Barcelona, Spain : 1998)

Romàn G.
PMID: 12847569
Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781.

The diagnosis and treatment of vascular dementia (VaD) are particularly challenging because of its multiple causal lesions and the variety of its clinical presentations. Even poststroke dementia cases may be due to preexisting Alzheimer's disease. Diagnostic criteria for clinical...

Cite
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000;36(9):641-53doi: 10.1358/dot.2000.36.9.593781.
Romàn, G. (2000). Perspectives in the treatment of vascular dementia. Drugs of today (Barcelona, Spain : 1998), 36(9), 641-53. https://doi.org/10.1358/dot.2000.36.9.593781
Romàn, G. "Perspectives in the treatment of vascular dementia." Drugs of today (Barcelona, Spain : 1998) vol. 36,9 (2000): 641-53. doi: https://doi.org/10.1358/dot.2000.36.9.593781
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781. PMID: 12847569.
Copy Download .nbib Format: NLM
"Messing with the mind": evolutionary challenges to human brain augmentation.

Frontiers in systems neuroscience

Saniotis A, Henneberg M, Kumaratilake J, Grantham JP.
PMID: 25324734
Front Syst Neurosci. 2014 Sep 30;8:152. doi: 10.3389/fnsys.2014.00152. eCollection 2014.

The issue of brain augmentation has received considerable scientific attention over the last two decades. A key factor to brain augmentation that has been widely overlooked are the complex evolutionary processes which have taken place in evolving the human...

Cite
Saniotis A, Henneberg M, Kumaratilake J, et al. "Messing with the mind": evolutionary challenges to human brain augmentation. Front Syst Neurosci. 2014;8:152doi: 10.3389/fnsys.2014.00152.
Saniotis, A., Henneberg, M., Kumaratilake, J., & Grantham, J. P. (2014). "Messing with the mind": evolutionary challenges to human brain augmentation. Frontiers in systems neuroscience, 8152. https://doi.org/10.3389/fnsys.2014.00152
Saniotis, Arthur, et al. ""Messing with the mind": evolutionary challenges to human brain augmentation." Frontiers in systems neuroscience vol. 8 (2014): 152. doi: https://doi.org/10.3389/fnsys.2014.00152
Saniotis A, Henneberg M, Kumaratilake J, Grantham JP. "Messing with the mind": evolutionary challenges to human brain augmentation. Front Syst Neurosci. 2014 Sep 30;8:152. doi: 10.3389/fnsys.2014.00152. eCollection 2014. PMID: 25324734; PMCID: PMC4179735.
Copy Download .nbib Format: NLM
Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction .

Frontiers in pharmacology

Cheng D, Yang XJ, Zhang L, Qin ZS, Li WQ, Xu HC, Zhang ZJ.
PMID: 34054561
Front Pharmacol. 2021 May 13;12:690256. doi: 10.3389/fphar.2021.690256. eCollection 2021.

Mitochondrial dysfunction with oxidative damage plays the fundamental roles in the pathogenesis of Alzheimer's disease. In traditional Chinese medicine (TCM) practice, animal tissue-derived gelatins are often used as nootropic agents to treat cognitive deterioration and senile dementia. Tortoise plastron...

Cite
Cheng D, Yang XJ, Zhang L, et al. Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction . Front Pharmacol. 2021;12:690256doi: 10.3389/fphar.2021.690256.
Cheng, D., Yang, X. J., Zhang, L., Qin, Z. S., Li, W. Q., Xu, H. C., & Zhang, Z. J. (2021). Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction . Frontiers in pharmacology, 12690256. https://doi.org/10.3389/fphar.2021.690256
Cheng, Dan, et al. "Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction ." Frontiers in pharmacology vol. 12 (2021): 690256. doi: https://doi.org/10.3389/fphar.2021.690256
Cheng D, Yang XJ, Zhang L, Qin ZS, Li WQ, Xu HC, Zhang ZJ. Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction . Front Pharmacol. 2021 May 13;12:690256. doi: 10.3389/fphar.2021.690256. eCollection 2021. PMID: 34054561; PMCID: PMC8155591.
Copy Download .nbib Format: NLM
Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease.

Medicinal chemistry (Shariqah (United Arab Emirates))

Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, Rekka EA.
PMID: 33050864
Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303.

BACKGROUND: Alzheimer's Disease (AD) is one of the most common neurodegenerative disorders, characterized by memory deficits and cognitive impairment. Acetylcholinesterase inhibitors, NMDA receptor antagonists and nootropic agents are used clinically, but they have only symptomatic efficacy, attributed to the...

Cite
Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, et al. Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease. Med Chem. 2021;17(10):1086-1103doi: 10.2174/1573406416666201013161303.
Papagiouvannis, G., Theodosis-Nobelos, P., Kourounakis, P. N., & Rekka, E. A. (2021). Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease. Medicinal chemistry (Shariqah (United Arab Emirates)), 17(10), 1086-1103. https://doi.org/10.2174/1573406416666201013161303
Papagiouvannis, Georgios, et al. "Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease." Medicinal chemistry (Shariqah (United Arab Emirates)) vol. 17,10 (2021): 1086-1103. doi: https://doi.org/10.2174/1573406416666201013161303
Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, Rekka EA. Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease. Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303. PMID: 33050864.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries